Currently predicting for Thu, 4 Jun 2026

GILD Prediction Chart

GILD Predictions History

Latest community submissions for GILD.
Predictor Target Session Target Price Result Direction Accuracy Score
May 21, 2026 $129.38 -1.00% $130.50 V 99.14% 3
May 21, 2026 $129.40 -0.99% $130.50 V 99.16% 3
May 21, 2026 $131.50 +0.62% $130.50 X 99.24% 2
May 21, 2026 Bullish $130.50 X 0
Feb 6, 2026 $147.92 -0.97% $152.50 X 96.99% 0
Feb 6, 2026 $148.46 -0.61% $152.50 X 97.35% 0
Tenaya Adrean Tenaya Adrean @TenayaAdrean.250731
Feb 6, 2026 Bullish $152.50 V 1
Oct 21, 2025 Bullish $124.08 V 1
Oct 14, 2025 $117.05 -0.98% $118.48 X 98.79% 1
Oct 14, 2025 $117.48 -0.62% $118.48 X 99.16% 2
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GILD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GILEAD SCIENCES
Gilead
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE